Advertisement

Pädiatrie pp 634-775 | Cite as

Infektionskrankheiten

  • H.-J. Schmitt
  • Th. Hauer
  • F. Daschner
  • M. Hufnagel
  • H. Scholz
  • B. Jüngst
  • H.-I. Huppertz
  • K.-M. Keller
  • H.-J. Christen
  • H. Eiffert
  • U. Heininger
  • D. Nadal
  • J. Forster
  • H. W. Kreth
  • V. Schuster
  • M. B. Krawinkel

Zusammenfassung

Infektionskrankheiten unterscheiden sich von allen anderen Krankheiten dadurch, daß sie nach einem Kontakt aus der Auseinandersetzung zweier Lebewesen entstehen — dem Menschen („Wirt“) auf der einen und dem Mikroorganismus („ungebetener Gast“) auf der anderen Seite. Verschiedene Fachdisziplinen haben im Lauf des letzten Jahrhunderts die 3 genannten Aspekte — Mikroorganismen, Makroorganismen und Kontakte — erforscht und sich dabei voneinander abgegrenzt. Im Laborbereich beschäftigt sich die medizinische Mikrobiologie mit den Mikroorganismen, die Immunologie mit den Makroorganismen. Die Hygiene untersucht die Kontaktmuster zwischen (ungebetenem) Gast und Wirt mit dem Ziel, Methoden zu entwickeln, die eine Übertragung des Erregers auf den Wirt verhindern. Daraus hat sich v. a. in den angelsächsischen Ländern die Infektionsepidemiologie entwickelt, welche die Regeln der Verbreitung von Infektionskrankheiten und ihren Erregern erforscht. Infektiologen haben spezielle Kenntnisse auf jedem der 4 vorgenannten Fachgebiete und betreuen als Ärzte für Kinderheilkunde oder innere Medizin eigenverantwortlich Patienten mit Infektionskrankheiten.

Literatur

  1. Fletcher RH, Fletcher SW, Wagner EH (1993) Clinical epidemiology. William & Wilkins, BaltimoreGoogle Scholar
  2. Schmitt HJ, Kontny U (1999) Infektionskrankheiten bei immunsupprimierten Kindern. In: Gutjahr P (Hrsg) Krebs bei Kindern und Jugendlichen. Deutscher Ärzteverlag, KölnGoogle Scholar
  3. Verne J (1996) Reise um die Welt in 80 Tagen. Fischer, StuttgartGoogle Scholar
  4. Centers for Disease Control and Prevention (1997) National Nosocomial Infections Surveillance (NNIS) Report. Data summary from October 1986-April 1997. Am J Infect Control 25: 477–487Google Scholar
  5. Ford-Jones EL, Mindorff CM, Langley JM (1989) Epidemiologic study of 4684 hospital-acquired infections in pediatric patients. Pediatr Infect Dis J 8: 668–675PubMedCrossRefGoogle Scholar
  6. Kappstein I (1997) Prävention von Infektionen in der Pädiatrie. In: Daschner F (Hrsg) Praktische Krankenhaushygiene und Umweltschutz, 2. Aufl. Springer, Berlin Heidelberg New York Tokyo, S 469–485Google Scholar
  7. Leclair JM, Freeman J, Sullivan BF, Crowley CM, Goldman DA (1987) Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N Engl J Med 317: 329–334PubMedCrossRefGoogle Scholar
  8. Levy J (1997) The pediatric patient. In: Wenzel RP (ed) Prevention and control of nosocomial infections, 3rd edn. Williams & Wilkins, Baltimore, pp 1039–1058Google Scholar
  9. Mayhall CG (1997) Hospital epidemiology and infection control. Williams & Wilkins, Baltimore, pp 485–564Google Scholar
  10. Raap D (1998) Nosokomiale Infektionen in der Pädiatrie. Dissertation aus der Universitätskinderklinik, Albert-Ludwigs-Universität FreiburgGoogle Scholar
  11. Waggoner-Fountain LA, Donowitz LG (1997) Infection in the newborn. In: Wenzel RP (ed) Prevention and control of nosocomial infections, 3rd edn. Williams & Wilkins, Baltimore, pp 1020–1038Google Scholar
  12. Hayden WR (1994) Sepsis terminology in pediatrics. J Pediatr 124: 657–658PubMedGoogle Scholar
  13. Kaplan SL (1998) Bacteremia and septic shock. In: Feigin RD, Cherry JD (eds) Textbook of pediatric infectious diseases. Saunders, Philadelphia, pp 807–820Google Scholar
  14. Säez-Llorens X, McCracken G (1993) Sepsis syndrome and septic shock in pediatrics: current concepts of terminology, pathophysiology, and management. J Pediatr 123: 497–508PubMedCrossRefGoogle Scholar
  15. Stehr K (1997) Sepsis. In: Deutsche Gesellschaft für Pädiatrische Infektiologie e.V. (Hrsg) Handbuch 1997, Infektionen bei Kindern und Jugendlichen. Futuramed, München, S 736–741Google Scholar
  16. Centers for Disease Control (1990) Case definitions for public health surveillance. MMWR 39 (RR-13): 38–39Google Scholar
  17. Chesuey PJ, Davis JP (1998) Toxic shock syndrome. In: Feigin RD, Cherry JD (eds) Textbook of pediatric infectious diseases. Saunders, Philadelphia, pp 830–852Google Scholar
  18. Kotb M (1995) Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 8: 411–426PubMedGoogle Scholar
  19. Resnick SD (1990) Toxic shock syndrom: recent developments in pathogenesis. J Pediatr 116: 321–328PubMedCrossRefGoogle Scholar
  20. Stevens DL (1992) Invasive group A streptococcus infections. Clin Infect Dis 14: 2–13PubMedCrossRefGoogle Scholar
  21. Stevens DL (1996) The toxic shock syndromes. Infect Dis Clin North Am 10: 727–746PubMedCrossRefGoogle Scholar
  22. The Working Group on Severe Streptococcal Infections (1993) Defining the group A streptococcal toxic shock syndrome. JAMA 269: 390–391Google Scholar
  23. Fernandez C, Gaspar C, Torrellas A,Vindel A, Saez-Nieto JA, Cruzet F, Aguilar L (1995) A double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of mupirocin calcium ointment for eliminating nasal carriage of staphylococcus aureus among hospital personnel. J Antimicrob Chemother 35: 399–408Google Scholar
  24. Mulligan ME, Murray-Leisure KA, Ribner BS et al. (1993) Methicillinresistent staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 94: 313–328PubMedCrossRefGoogle Scholar
  25. Rupp ME, Archer GL (1994) Coagulase-negative staphylococci: patho- gens associated with medical progress. Clin Infect Dis 19: 231–245PubMedCrossRefGoogle Scholar
  26. Witte W, Kresken M, Braulke Ch, Cuny Ch (1997) Increasing incidence and widespread dissemination of methicillin-resistant staphylococcus aureus ( MRSA) in hospitals in central Europe, with special reference to German hospitals. Clin Microbiol Infect 3: 414–422Google Scholar
  27. Bisno AL, Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH (1997) Diagnosis and management of group A streptococcal pharyngitis: a practice guidline. Clin Infect Dis 25: 574–583PubMedCrossRefGoogle Scholar
  28. Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI) (1997) Handbuch. Infektionen bei Kindern und Jugendlichen, 2. Aufl. Futuramed, München, 527–536Google Scholar
  29. Domingo P, Barquet N, Alvarez M, Coll P, Nava J, Garau J (1997) Group B streptococcal meningitis in adults: report of twelve cases and review. Clin Infect Dis 25: 1180–1187PubMedCrossRefGoogle Scholar
  30. Kolben M, Höss C, Proquitté H, Milatovic D, Zimmermann A, Roos R (1998) Peripartales Management bei mütterlicher Streptokokken B-Kolonisation. Pädiatr Prax 54: 21–26Google Scholar
  31. Low DE, McGeer A (1998) Skin and soft tissue infection: necrotizing fasciitis. Curr Opin Infect Dis 11: 119–123PubMedCrossRefGoogle Scholar
  32. Raz R, Elchanan G, Colodner R, Reiss S, Schvartzman P, Tabenkin H, Les-hem Y (1995) Penicillin V twice daily vs. four times daily in the treatment of streptococcal pharyngitis. Infect Dis Clin Pract 1: 50–54CrossRefGoogle Scholar
  33. Scholz H, Noack R (1996). Antimikrobiotika im Kindes- und Jugendalter, 4. Aufl. Ulistein Mosby, München, S 94–97Google Scholar
  34. Appelbaum PC (1996) Epidemiology and in vitro susceptibility of drug-resistent streptococcus pneumoniae. Pediatr Infect Dis J 15: 932–939PubMedCrossRefGoogle Scholar
  35. Centers for Disease Control and Prevention (CDC) (1997) Prevention of pneumococcal disease. Recommendations of the advisory committee on immunization practices (ACIP). Morbidity and mortality. Weekly report 46/RR-8: 1–24Google Scholar
  36. Nationales Referenzzentrum für Meningokokken (1997). Jahresbericht 1996. Bundesgesundhbl 8: 284–288Google Scholar
  37. Robert Koch Institut (1998) Meningokokkenerkrankungen in Deutschland 1997 und in Europa. Untersuchung eines Ausbruchs von Meningokokkenerkrankungen in Niederbayern. Zum Vorgehen bei Ausbrüchen von Infektionen durch Meningokokken der Serogruppe C. Epidemiolog Bulletin/ 63–67Google Scholar
  38. Kries R, Heinrich B, Böhm O, Windfuhr A, Helwig H (1997) Systemische Haemophilus-influenzae-Erkrankungen in Deutschland: 1992–1995. Monatsschr Kinderheilkd 145: 136–143CrossRefGoogle Scholar
  39. Brady MT, Feigin RD (1998) Pseudomonas and related species. In: Fei-gin RD, Cherry JD (eds) Textbook of pediatric infectious diseases, 4th edn. Saunders, Philadelphia, pp 1401–1413Google Scholar
  40. Cheng K, Smyth RL, Govan JR et al. (1996) Spread of (3-lactam-resistent Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 348: 639–642PubMedCrossRefGoogle Scholar
  41. Govan JR, Deretic V (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60: 539–574PubMedGoogle Scholar
  42. Lau LS, Bin G, Jaovisidua S, Danker W, Sartoris DJ (1997) Cost effectiveness of magnetic resonance imaging in diagnosing Pseudomonas aeruginosa infection after puncture wound. J Foot Ankle Surg 36: 36–43PubMedCrossRefGoogle Scholar
  43. Acheson DWK, Keusch GT (1998) Diarrhea- and dysentery-causing Escherichia coli. In: Feigin RD, Cherry JD (eds) Textbook of pediatric infectious diseases. Saunders, Philadelphia, pp 1282–1298Google Scholar
  44. Huppertz HI, Busch D, Schmidt H, Aleksic S, Karch H (1996) Diarrhea in young children associated with Escherichia coli non-0157 producing Shiga-like toxin. J Pediatr 128: 341–346PubMedCrossRefGoogle Scholar
  45. Huppertz HI, Rutkowski S, Aleksic S, Karch H (1997) Acute and chronic diarrhea and abdominal colic associated with enteroaggregative Escherichia coli in young children living in Western Europe. Lancet 349: 1660–1662PubMedCrossRefGoogle Scholar
  46. Nataro JP, Kaper JB (1998) Diarrheagenic Escherichia coli. Clin Microbiol Rev 11: 142–201PubMedGoogle Scholar
  47. Bitzan M (1997) Salmonella-Infektionen. In: Deutsche Gesellschaft für Pädiatrische Infektiologie (Hrsg) Handbuch. Infektionen bei Kindern und Jugendlichen, 2. Aufl. Futuramed, München, S 496–506Google Scholar
  48. Gomez HF, Cleary TG (1998) Salmonella. In: Feigin RD, Cherry JD (eds) Textbook of pediatric infectious diseases, 4th edn. Saunders, Philadelphia, pp 1321–1334Google Scholar
  49. Jones BD, Falkow S (1996) Salmonellosis, host immune responses and bacterial virulence determinants. Ann Rev Immunol 14: 533–561CrossRefGoogle Scholar
  50. Schutze GE, Schutze SE, Kirby RS (1997) Extraintestinal salmonellosis in a children’s hospital. Pediatr Infect Dis J 16: 482–485PubMedCrossRefGoogle Scholar
  51. Ahmed F, Clemens JD, Roa MR, Ansaruzzaman M, Hague E (1997) Epidemiology of shigellosis among children exposed to cases of Shigella dysentery. Am J Trop Med Hyg 56: 258–264PubMedGoogle Scholar
  52. Benenson AS (1995) Control of communicable diseases manual. American Public Health Association, Washington DC, pp 353–358, 524–527Google Scholar
  53. Kihlstrom E, Foberg U, Bengtsson A (1992) Intestinal symptoms and serological response in patients with complicates and uncomplicates Yersinia enterocolitica infections. Scand J Infect Dis 24: 57–63PubMedCrossRefGoogle Scholar
  54. Blaser MJ, Relier LB (1981) Campylobacter enteritis. N Engl J Med 305: 1444–1452PubMedCrossRefGoogle Scholar
  55. Korinthenberg R, Sauer M (1992) Das Guillain-Barré-Syndrom im Kindesalter. Monatsschr Kinderheilkd 140: 792–798PubMedGoogle Scholar
  56. Wong SN, Tam AYC, Yuen KY (1990) Campylobacter infection in the neonate: case report und review of the literature. Pediatr Infect Dis J 9: 665–669PubMedGoogle Scholar
  57. Yuki N (1997) Molecular mimicry between gangliosides and lipopolysaccharides of campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome. J Infect Dis 176 (Suppl 2): 5150–5153Google Scholar
  58. Fang GD, Yu VL, Vickers RM (1989) Disease due to the Legionellaceae (other than Legionella pneumophila): historical, microbiological, clinical and epidemiological review. Medicine 68: 116–132PubMedCrossRefGoogle Scholar
  59. Fraser DW, Tsai T, Orenstein W (1977) Legionnaires’ disease: discription of an outbreak of pneumonia. N Engl J Med 297: 1189–1197PubMedCrossRefGoogle Scholar
  60. Baum SG (1995) Mycoplasmal diseases. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious diseases, 4th edn. Churchill Livingstone, New York/NY, pp 1701–1713Google Scholar
  61. Jacobs E (1993) Serological diagnosis of Mycoplasma pneumoniae infections: a critical review of current procedures. Clin Infec Dis 17 (Suppl 1): 79–82CrossRefGoogle Scholar
  62. Taylor-Robinson D (1996) Infections due to species of Mycoplasma and Ureaplasma: an update. Clin Infect Dis 23: 671–684PubMedCrossRefGoogle Scholar
  63. Freidank H (1992) Akute respiratorische Infektionen durch Chlamydia pneumoniae. Dtsch Med Wochenschr 117: 187–191PubMedCrossRefGoogle Scholar
  64. Grayston JT, Campell LA, Kuo CC, Mordhorst CH, Saikku P, Thom DH, Wang SP (1990) A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 161: 618–625Google Scholar
  65. Hahn DL, Dogde R, Golubjatnikow R (1991) Association of Chlamydia pneumoniae infection with wheezing, asthmatic bronchitis and adult onset asthma. J Am Med Assoc 266: 225–230CrossRefGoogle Scholar
  66. Höger P (1997) Chlamydien-Infektionen. In: Deutsche Gesellschaft für Pädiatrische Infektiologie e.V. (Hrsg) Handbuch 1997. Infektionen bei Kindern und Jugendlichen. Futuramed, München, S 211–218Google Scholar
  67. Kuo CC, Jackson LA, Campell LA, Grayston JT (1995) Chlamydia pneumoniae ( TWAR ). Clin Micobiol Rev 8: 451–461Google Scholar
  68. Saikku P, Leinonen M, Teukanen L et al. (1992) Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med 26: 273–278CrossRefGoogle Scholar
  69. Committee on Infectious Diseases (1997) Chlamydia psittaci. In: American Academy of Pediatrics (ed) Report of the Committee on Infectious Diseases (Red Book). American Academy of Pediatrics, Elk Grove Village/IL, pp 169–170Google Scholar
  70. Höger P (1997) Chlamydien-Infektionen. In: Deutsche Gesellschaft für Pädiatrische Infektiologie e.V. (Hrsg) Handbuch 1997, Infektionen bei Kindern und Jugendlichen. Futuramed, München, S 211–218Google Scholar
  71. Yung AP, Grayson ML (1988) Psittacosis–a review of 135 cases. Med J Aust 148: 228–233PubMedGoogle Scholar
  72. Christen HJ, Hanefeld F (1993) Die Lyme-Borreliose im Kindesalter. Monatsschr Kinderheilkd 141: 513–526PubMedGoogle Scholar
  73. Christen HJ, Hanefeld F, Eiffert H et al. (1993) Epidemiology and clinical manifestations of Lyme borreliosis in childhood. Acta Paediatr 82 (Suppl386): 1–75CrossRefGoogle Scholar
  74. Heininger U, Zimmermann T, Schoerner C et al. (1993) Zeckenstich und Lyme-Borreliose. Monatsschr Kinderheilkd 141: 874–877PubMedGoogle Scholar
  75. Huppertz HI, Karch H, Suschke HJ et al. (1995) Lyme arthritis in European children and adolescents. Arthritis Rheum 38: 361–368PubMedCrossRefGoogle Scholar
  76. Barbour AG, Hayes SF (1986) Biology of Borrelia species. Microbiol Rev 50: 381–400PubMedGoogle Scholar
  77. Dworking MS, Anderson DE, Schwan TG et al. (1998) Tick-borne relapsing fever in the northwestern United States and southwestern Canada. Clin Infect Dis 26: 122–131CrossRefGoogle Scholar
  78. Jongen VH, Roosmalen J van, Tiems J et al. (1997) Tick-borne relapsing fever and pregnancy outcome in rural Tanzania. Acta Obstet Gynecol Scand 76: 834–838PubMedCrossRefGoogle Scholar
  79. Jackson LA, Kaufmann AF, Adams WG et al. (1993) Outbreak of leptospirosis associated with swimming. Pediatr Infect Dis 12: 48–54CrossRefGoogle Scholar
  80. Krauss H, Weber A (Hrsg) (1986) Zoonose, von Tier zu Mensch übertragbare Infektionskrankheiten–Leitfaden für die Praxis. Dtsch Ärzte-Verlag, Köln, S 34–36Google Scholar
  81. Marotto PCF, Marotto MS, Santos DL et al. (1997) Outcome of leptospirosis in children. Am J Trop Med Hyg 56: 307–310PubMedGoogle Scholar
  82. Wesley FR (1995) Leptospirosis. Clin Infect Dis 21: 1–8CrossRefGoogle Scholar
  83. Nolte FS, Metchock B (1995) Mycobacterium. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds) Manual of clinical microbiology. American Society for Microbiology, Washington DC, pp 400–437Google Scholar
  84. Frieden TR, Sherman LF, Maw KL et al. (1996) A multi-institutional outbreak of highly drug-resistance tuberculosis. J Am Med Assoc 276: 1229–1235CrossRefGoogle Scholar
  85. Inselman LS (1996) Tuberculosis in children: an update. Pediatr Pulmonol 21: 101–120PubMedCrossRefGoogle Scholar
  86. KcKenna MT, McCray E, Onorato I (1995) The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993. N Engl J Med 332: 1071–1976CrossRefGoogle Scholar
  87. Knuf M, Habermehl P, Schuind A, Zepp F, Schmitt HJ (1996) Wirksamkeit der BCG-Impfung. Monatsschr Kinderheilkd 144: 648–654Google Scholar
  88. Smith S, Jacobs RF, Wilson CB (1997) Immunobiology of childhood tuberculosis: a window on the ontogeny of cellular immunity. Pediatrics 131: 16–26CrossRefGoogle Scholar
  89. Ridley DS, Jopli WH (1966) Classification of leprosy according to immunity. A five group system. Int J Lepr Other Mycobact Dis 34: 255–273Google Scholar
  90. Heininger U (1995) Gemeinsamkeiten und Differenzen von Pertussis und Parapertussis. Pädiatr Prax 48: 437–445Google Scholar
  91. Heininger U, Stammwitz J, Stehr K (1996) Prävalenz von Antikörpern gegen B. pertussis bei Kindern und Jugendlichen ohne vorausgegangene Pertussisimpfung. Monatsschr Kinderheilkd 144: 906–909CrossRefGoogle Scholar
  92. Heininger U, Klich K, Stehr K, Cherry JD (1997) Clinical findings in Bordetella pertussis infections: results of a prospective multicenter surveillance study. Pediatrics 1oo:www.pediatrics.org/cgi/content/full/ 100/6/emoGoogle Scholar
  93. Mortimer EA (1990) Pertussis and its prevention: a family affair. J Infect Dis 161: 473–479PubMedCrossRefGoogle Scholar
  94. Schläpfer G, Cherry JD, Heininger U et al. (1995) Polymerase chain reaction identification of Bordetella pertussis infections in vaccinees and family members in a pertussis vaccine efficacy trial in Germany. Ped Inf Dis J 14: 209–214CrossRefGoogle Scholar
  95. Schmitt H-J (1996) Acellular pertussis vaccines: the final countdown. Eur J Pediatr 155: 74–76PubMedCrossRefGoogle Scholar
  96. Schreiner MS, Field E, Ruddy R (1991) Infant botulism: a review of 12 years’ experience at the Children’s Hospital of Philadelphia. Pediatrics 87: 159–165PubMedGoogle Scholar
  97. Jacobs RF, Narain JP (1983) Tularemia in children. Pediatr Infect Dis J 2: 487–491CrossRefGoogle Scholar
  98. Lubani MM, Dudkin KI, Sharda DC et al. (1989) A multicenter therapeutic study of two children with brucellosis. Pediatr Inf Dis J 8: 75–78CrossRefGoogle Scholar
  99. McLauchlin J (1990) Human listeriosis in Britain 1967–85, a summary of 722 cases. Epidemiol Infect 104: 181–201PubMedCrossRefGoogle Scholar
  100. Ahmadsyah J, Salim A (1985) Treatment of tetanus: an open study to compare the efficacy of procaine penicillin and metronidazole. Br Med J 291: 648–650CrossRefGoogle Scholar
  101. Behring E, Kitasato S (1890) Über das Zustandekommen der Diphtherie-Immunität und der Tetanus-Immunität bei Tieren. Dtsch Med Wochenschr 16: 1113–1114CrossRefGoogle Scholar
  102. Smego RA Jr, Foglia G (1998) Actinomycosis. Clin Infect Dis 26: 1255–1263CrossRefGoogle Scholar
  103. Beaman BL, Saubolle MA, Wallace RJ (1995) Nocardia, Rhodococcus, Streptomyces, Oerskovia and other aerobic Actinomycetes of medical importance. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds) Manual of clinical microbiology. American Society for Microbiology, Washington DC, pp 379–399Google Scholar
  104. Raoult D, Marrie T (1995) Q fever. Clin Infect Dis zo: 489–496 Reimer LG (1993) Q fever. Clin Microbiol Rev 6: 193–198Google Scholar
  105. Bass JW, Vincent JM, Person DA (1997) The expanding spectrum of Bartonella infections: II. Cat-scratch disease. Pediatr Infect Dis J 16: 163–179Google Scholar
  106. Jacobs RF, Schutze GE (1998) Bartonella henselae as a cause of prolongued fever and fever of unknown origin. Clin Infect Dis 26: 80–84PubMedCrossRefGoogle Scholar
  107. Nadal D, Zbinden R (1996) Erkrankungen durch Bartonellen. Internist 37: 890–894PubMedGoogle Scholar
  108. Maurin M, Birtles R, Raoult D (1998) Current knowledge of Bartonella species. Eur J Clin Microbiol Infect Dis 16: 487–506CrossRefGoogle Scholar
  109. Maurin M, Raoult D (1996) Bartonella ( Rochalimaea) quintana. Clin Microbiol Rev 9: 273–92Google Scholar
  110. Raoult D, Marrie TJ (1995) Q fever. Clin Infect Dis 20: 489–96CrossRefGoogle Scholar
  111. Raoult D, Roux V (1997) Rickettsioses as paradigms of new or emerging infectious diseases. Clin Microbiol Rev 10: 694–719PubMedGoogle Scholar
  112. Brandt CD, Kim HW, Vargosko AJ (1969) Infections in 18.000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to serologic type and illness syndrome. Am J Epidemiol 90: 484–500Google Scholar
  113. Cherry JD (1998) Adenoviruses. In: Feigin RD, Cherry JD (eds) Textbook of pediatric infectious diseases, 4th edn. Saunders, Philadelphia, 1666–1684Google Scholar
  114. Mc Carthy AJ, Bergin M, DeSilva LM, Stevens M (1995) Intravenous ribavirin therapy for disseminated adenovirus infection. Ped Inf Dis J 14: 1003–1004CrossRefGoogle Scholar
  115. Winter GF, Hallam NF, Hargreaves FD, Moleyneaux PJ, Burns SM, Inglis JM (1996) Respiratory viruses in a hospitalizid paediatric population in Edinburgh 1985–1994. J Infect 33: 207–211PubMedCrossRefGoogle Scholar
  116. Zahradnik JM, Spencer MJ, Porter DD (1980) Adenovirus infection in the immunocompromised patient. Am J Med 68: 725–732PubMedCrossRefGoogle Scholar
  117. Carlsen KH (1997) Markers of airway inflammation in preschool wheezers. Monaldi Arch Chest Dis 52: 455–460PubMedGoogle Scholar
  118. Gern JE, Galagan DM, Jarjour NN, Dick EC, Busse WW (1997) Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 155: 1159–1161PubMedCrossRefGoogle Scholar
  119. Grunberg K, Timmers MC, Smits HH et al. (1997) Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo. Clin Exp Allergy 27: 36–45PubMedCrossRefGoogle Scholar
  120. Turner RB (1997) Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol 78: 531–539PubMedCrossRefGoogle Scholar
  121. Baboonian C, Davies MJ, Booth JC, McKenna WJ (1997) Coxsackie B viruses and human heart disease. Curr Top Microbiol Immunol 223: 31–52PubMedCrossRefGoogle Scholar
  122. Cherry JD (1998) Enteroviruses: Coxsackieviruses, Echoviruses, and Polioviruses. In: Feigin RD, Cherry JD (eds) Textbook of pediatric infectious diseases, 4th edn. Saunders, Philadelphia, pp 1787–1839Google Scholar
  123. Foulis AK, McGill M, Farquharson MA, Hilton DA (1997) A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM. Diabetologia 40: 53–61PubMedCrossRefGoogle Scholar
  124. Marshall GS, Hauck MA, Buck G, Rabalais GP (1997) Potential cost savings through rapid diagnosis of enteroviral meningitis. Pediatr Infect Dis J 16: 1086–1087PubMedCrossRefGoogle Scholar
  125. Tangermann RH, Aylward B, Birmingham M et al. (1997) Current status of the global eradication of poliomyelitis. World Health Stat Q 50: 188–194PubMedGoogle Scholar
  126. Geizen WP (1998) Influenza viruses. In: Feigin RD, Cherry JD (eds) Textbook of pediatric infectious diseases, 4th edn. Saunders, Philadelphia, pp 2024–2041Google Scholar
  127. Kinney JS, Robertsen CM, Johnson KM et al. (1995) Seasonal respiratory viral infections. Impact on infants with chronic lung disease following discharge from the neonatal intensive care unit. Arch Pediatr Adolesc Med 149: 81–85Google Scholar
  128. Lina B, Valette M, Foray S et al. (1996) Surveillance of community-acquired viral infections due to respiratory viruses in Rhone-Alpes (France) during winter 1994 to 1995. I Clin Microbiol 34: 3007–3011Google Scholar
  129. Trigg CJ, Nicholson KG, Wang JH et al. (1996) Bronchial inflammation and the common cold: a comparison of atopic and non-atopic individuals. Clin Exp Allergy 26: 665–676PubMedCrossRefGoogle Scholar
  130. Knott AM, Long CE, Hall CB (1994) Parainfluenza viral infections in pediatric outpatients: seasonal patterns and clinical characteristics. Pediatr Infect Dis J 13: 269–273PubMedCrossRefGoogle Scholar
  131. Lindquist SW, Darnule A, Istas A, Demmler GJ (1997) Parainfluenza virus type 4 infections in pediatric patients. Pediatr Infect Dis J 16: 34–38PubMedCrossRefGoogle Scholar
  132. Marx A, Török TJ, Holman RC, Clarke MJ, Anderson LJ (1997) Pediatric hospitalization for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics. J Infect Dis 175: 1423–1427CrossRefGoogle Scholar
  133. Reed G, Jewett PH, Thompson J, Tollefson S, Wright PF (1997) Epidemiology and clincal impact of parainfluenza virus infections in otherwise healthy infants and young children 5 years old. J Infect Dis 175: 807–813PubMedCrossRefGoogle Scholar
  134. Anderson LJ, Heilman CA (1995) Protective and disease-enhancing im- mune responses to respiratory syncytial virus. J Infect Dis 171: 1–7PubMedCrossRefGoogle Scholar
  135. Hall CB (1998) Respiratory syncytial virus. In: Feigin RD, Cherry JD (eds) Textbook of pediatric infectious diseases, 4th edn. Saunders, Philadelphia, pp 2084–2111Google Scholar
  136. Wang EE, Law BJ, Stephens D (1995) Pediatric Investigators Collaborative Network on Infections in Canada ( PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 126: 212–219Google Scholar
  137. Brodsky AL (1972) Atypical measles: severe illness in recipients of killed measles virus vaccine upon exposure to natural infection. JAMA 222: 1415–1416PubMedCrossRefGoogle Scholar
  138. Coutsoudi A, Broughton M, Coovadia HH (1992) Vitamin A supplementation reduces measles morbidity in young African children: a randomized placebo-controlled, double-blind trial. Am J Clin Nutr 54: 890–895Google Scholar
  139. Forni AL, Schluger NW, Robert RB (1994) Severe measles pneumonitis in adults: evaluation of clinical characteristics and therapy with intravenous ribavirin. Clin Infect Dis 19: 454–462PubMedCrossRefGoogle Scholar
  140. Gendelman KE, Wolinsky JS, Johnson RT et al. (1984) Measles encephalitis: lack of evidence of viral invasion of the nervous system and quantitative study of the nature of demyelination. Ann Neurol 15: 353–360PubMedCrossRefGoogle Scholar
  141. Karp CL, Wysocka M, Wahl LM et al. (1996) Mechanism of suppression of cell-mediated immunity by measles virus. Science 273: 228–231PubMedCrossRefGoogle Scholar
  142. Markowitz LE, Chandler FW, Roldan EO et al. (1988) Fatal measles pneu- monia without rash in a child with AIDS. J Infect Dis 158: 480–483PubMedCrossRefGoogle Scholar
  143. Mustafa MM, Weitman SD, Winick NJ, Bellini WJ et al. (1993) Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature. Clin Infect Dis 16: 654–660PubMedCrossRefGoogle Scholar
  144. Brown P (1988) Human growth hormone therapy and Creutzfeldt-Jakob disease: A drama in three acts. Pediatrics 81: 85–92PubMedGoogle Scholar
  145. Dörries K (1997) New aspects in the pathogenesis of polyomavirus-induced disease. Adv Virus Res 48: 205–261PubMedCrossRefGoogle Scholar
  146. Kretzschmar H (1999) Transmissible spongiforme Enzephalopathien (Prionkrankheiten). In: Hopf H Ch, Deuschl G, Diener H Ch (Hrsg) Neurologie in Praxis and Klinik, 2. Aufl. Thieme, Stuttgart New YorkGoogle Scholar
  147. Martin R, Marquardt P, O’Shea S, Borkenstein M, Kreth HW (1989) Virus specific and autoreactive T cell lines isolated from cerebrospinal fluid of a patient with chronic rubella panencephalitis. J Neuroimmunol 23: 1–10PubMedCrossRefGoogle Scholar
  148. Miller Chr, Farrington CP, Marbert K (1992) The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970–1989. Int J Epidemiol 21: 998–1006CrossRefGoogle Scholar
  149. Nasemann JE, Schmid C, Schneider A et al. (1996) Äußere Retinitis als Frühsymptom bei subakut sklerosierender Panenczephalitis ( SSPE ). Klin Monatsbl Augenheilkd 206: 122–127Google Scholar
  150. Prusiner SB (1991) Molecular biology of prion diseases. Science 252: 1515–1522PubMedCrossRefGoogle Scholar
  151. Redfearn A, Pennie RA, Mahony JB, Dent PB (1993) Progressive multifocal leukoencephalopathy in a child with immunodeficiency and hyperimmunoglobulinemia M. Pediatr Infect Dis J 12: 399–401PubMedCrossRefGoogle Scholar
  152. Steelman VG (1994) Creutzfeldt-Jakob disease: recommendations for infection control. Am J Infect Control 22: 312–318PubMedCrossRefGoogle Scholar
  153. Vandersteenhoven JJ, Dbaibo G, Boyko AB et al. (1992) Progressive multi-focal leukoencephalopathy in pediatric acquired immunodeficiency syndrome. Pediatr Infect Dis 10: 232–237Google Scholar
  154. Will RG, Ironside JW, Zeidler M et al. (1996) A new variant of CreutzfeldtJakob disease in the UK. Lancet 347: 921–925PubMedCrossRefGoogle Scholar
  155. Zwiauer K, Fostenpointner E, Popow-Kraupp Th, Hauser E, Jellinger KA (1995) Rapid progressive subacute sclerosing panencephalitis after perinatally acquired measles virus infections. Lancet 345: 11–24CrossRefGoogle Scholar
  156. Bayer WL, Sherman FE, Michaels PM, Szeto ILF, Lewis JM (1965) Purpu- ra in congenital and acquired rubella. N Engl J Med 273: 1362–1366PubMedCrossRefGoogle Scholar
  157. Bitzan M (1987) Rubella myelitis and encephalitis in childhood: a report on 2 cases with magnetic resonance imaging. Neuropediatrics 18: 84–87PubMedCrossRefGoogle Scholar
  158. Dwyer DE, Hueston L, Field PR, Cunningham AL, North K (1992) Acute encephalitis complicating rubella virus infection. Ped Infect Dis J 11: 238–340CrossRefGoogle Scholar
  159. Enders G, Knotek F (1989) Rubella total antibody avidity and IgG subclass-specific antibody avidity assay and their role in the differentiation between primary rubella and rubella reinfection. Infection 11: 216–226Google Scholar
  160. Frenkel LM, Nielsen K, Garakian A, Jin R, Wolinsky JS, Cherry JD (1996) A search for persistent rubella virus infection in persons with chronic symptoms after rubella and rubella immunization and in a patient with juvenile rheumatoid arthritis. Clin Infect Dis 22: 287–294PubMedCrossRefGoogle Scholar
  161. Blom L, Nyström L, Dahlquist G (1991) The Swedish childhood diabetes study. Vaccinations and infections as risk determinants for diabetes in childhood. Diabetologia 34: 176–181Google Scholar
  162. Casella R, Leibundgut B, Lehmann K, Gasser TC (1997) Mumps orchitis: report of a mini-epidemic. J Uro1158: 2158–2161Google Scholar
  163. Hall R, Richards H (1987) Hearing loss due to mumps. Arch Dis Child 62: 189–192PubMedCrossRefGoogle Scholar
  164. Helmke K, Otten A, Willems WR et al. (1986) Islet cell antibodies and the development of diabetes mellitus in relation to mumps infection and mumps vaccination. Diabetologia 29: 30–33PubMedCrossRefGoogle Scholar
  165. Vaheri A, Julkunen I, Koskiniemi ML (1982) Chronic encephalomyelitis with specific increase in intrathecal mumps antibodies. Lancet 2: 685–688PubMedCrossRefGoogle Scholar
  166. Vandvik B, Norrby E, Steen-Johnson J, Stensvold K (1978) Mumps meningitis: prolonged pleocytosis and occurrence of mumps-specific oligoclonal IgG in the cerebrospinal fluid. Eur Neurol 17: 13–22PubMedCrossRefGoogle Scholar
  167. Asano Y, Yoshikawa T, Suga S et al. (1994) Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum). Pediatrics 93: 104–108PubMedGoogle Scholar
  168. Braun DK, Dominguez G, Pellett PE (1997) Human herpesvirus 6. Clin Microbiol Rev 10: 521–567PubMedGoogle Scholar
  169. Campadelli-Fiume G, Mirandola P, Menotti L (1999) Human herpesvirus 6: an emerging pathogen. Emerg Infect Dis 5: 353–366PubMedCrossRefGoogle Scholar
  170. Levy JA (1997) Three new human herpesviruses (HHV6, 7, and 8). Lancet 349: 558–563PubMedGoogle Scholar
  171. Takahashi Y, Yamada M, Nakamura J et al. (1997) Transmission of human herpesvirus 7 through multigeneration families in the same household. Pediatr Infect Dis 16: 975–978CrossRefGoogle Scholar
  172. Torigoe S, Kumamoto T, Koide W, Taya K, Yamanishi K (1995) Clinical manifestations associated with human herpesvirus 7 infection. Arch Dis Child 72: 518–519PubMedCrossRefGoogle Scholar
  173. Blackbourn DJ, Lennette ET, Ambroziak J, Mourich DV, Levy JA (1998) Human herpesvirus 8 detection in nasal secretions and saliva. J Infect Dis 177: 213–216PubMedCrossRefGoogle Scholar
  174. Kikuta H, Itakura O, Ariga T, Kobayashi K (1997) Detection of human herpesvirus 8 DNA sequences in peripheral blood mononuclear cells of children. J Med Viro153: 81–84Google Scholar
  175. Lennette ET, Blackbourn DJ, Levy JA (1996) Antibodies to human herpesvirus type 8 in the general population and Kaposi’s sarcoma patients. Lancet 348: 858–861PubMedCrossRefGoogle Scholar
  176. Merelli E, Bedin R, Sota P et al. (1997) Human herpes virus 6 and human herpes virus 8 DNA sequences in brains of multiple sclerosis patients, normal adults and children. J Neurol 244: 450–454PubMedCrossRefGoogle Scholar
  177. Anderson MJ, Higgins PG, David LR et al. (1985) Experimental parvoviral infection in humans. J Infect Dis 152: 257–265PubMedCrossRefGoogle Scholar
  178. Brown KE, Hibbs JR, Gallinella G, Anderson SM, Lehman ED, McCarthy P, Young NS (1994) Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen) N Engl J Med 330: 1192–1196PubMedGoogle Scholar
  179. Heegard ED, Hornsleth A (1995) Parvovirus: the expanding spectrum of disease. Acta Paediatr 84: 109–117CrossRefGoogle Scholar
  180. Levy R, Weissman A, Blomberg G, Hagy ZJ (1997) Infection by parvovirus B19 during pregnancy: a review. Obstet Gynecol Sury 52: 254–259CrossRefGoogle Scholar
  181. Nguyen QT, Sifer C, Schneider V et al. (1999) Novel human erythrovirus associated with transient aplastic anemia. J Clin Microbiol 37: 2483–2487PubMedGoogle Scholar
  182. Young NS (1996) Parvovirus infection and its treatment. Clin Exp Immunol 104 (Suppl 1): 26–30PubMedGoogle Scholar
  183. Kimberlin D, Powell D, Gruber W et al. (1996) Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J 15: 247–254PubMedCrossRefGoogle Scholar
  184. Kimura H, Aso K, Kuzushima K, Hanada N, Shibata M, Morishima T (1992) Relapse of herpes simplex encephalitis in children. Pediatrics 89: 891–894PubMedGoogle Scholar
  185. Wagstaff AJ, Faulds D, Goa KL (1994) Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 47: 153–205Google Scholar
  186. Whitley RJ, Kimberlin DW, Roizman B (1998) Herpes simplex viruses. Clin Infect Dis 26: 541–555PubMedCrossRefGoogle Scholar
  187. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M (1994) Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 343: 1548–1551PubMedCrossRefGoogle Scholar
  188. Kennedy PG, Grinfeld E, Gow JW (1998) Latent varicella-zoster virus is located predominantly in human trigeminal ganglia. Proc Natl Acad Sci USA 95: 4658–4662PubMedCrossRefGoogle Scholar
  189. Lin TY, Huang YC, Ning HC, Hsueh C (1997) Oral acyclovir prophylaxis after intimate contact. Pediatr Infect Dis J 16: 1162–1165PubMedCrossRefGoogle Scholar
  190. Ozaki T, Kajita Y, Asano Y, Aono T, Yamanishi K (1994) Detection of varicella-zoster virus DNA in blood of children with varicella. J Med Virol 44: 263–265PubMedCrossRefGoogle Scholar
  191. Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA (1992) Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 11: 93–99PubMedCrossRefGoogle Scholar
  192. Boppana SB, Fowler KB, Vaid Y, Hedlund G, Stagno S, Britt WJ, Pass RF (1997) Neuroradiographic findings in the newborn period and longterm outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics 99: 409–414PubMedCrossRefGoogle Scholar
  193. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA (1992) The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 326: 663–667PubMedCrossRefGoogle Scholar
  194. Meer JT van der, Drew WL, Bowden RA et al. (1996) Summary of the international consensus symposium on advances in the diagnosis, treatment and prophylaxis of cytomegalovirus infection. Antiviral Res 32: 119–140CrossRefGoogle Scholar
  195. Vochem M, Hamprecht K, Jahn G, Speer CP (1998) Transmission of cytomegalovirus to preterm infants through breast milk. Pediatr Infect Dis J 17: 53–58PubMedCrossRefGoogle Scholar
  196. Whitley RJ, Cloud G, Gruber W et al. (1997) Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. J Infect Dis 175: 1080–1086PubMedCrossRefGoogle Scholar
  197. Callan MF, Tan L, Annels N et al. (1998) Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 187: 1395–1402PubMedCrossRefGoogle Scholar
  198. Imai S, Sugiura M, Oikawa O et al. (1996) Epstein-Barr virus ( EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection. Blood 87: 1446–1457Google Scholar
  199. Okano M, Matsumoto S, Osato T, Sakiyama Y, Thiele GM, Purtilo DT (1991) Severe chronic active Epstein-Barr virus infection syndrome. Clin Microbiol Rev 4: 129–135PubMedGoogle Scholar
  200. Tynell E, Aurelius E, Brandell A et al. (1996) Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study. J Infect Dis 174: 324–331PubMedCrossRefGoogle Scholar
  201. Bielefeldt-Ohmann H (1997) Pathogenesis of dengue virus diseases: missing pieces in the jigsaw. Trends Microbiol 5: 409–413PubMedCrossRefGoogle Scholar
  202. Bitzan M (1997) Hämorrhagische Fieber und Hantavirus-Infektionen. In: Deutsche Gesellschaft für Pädiatrische Infektiologie (Hrsg) Handbuch. Infektionen bei Kindern und Jugendlichen, 2. Aufl. Futuramed, München, S 295–307Google Scholar
  203. Kautner I, Robinson MJ, Kuhnle U (1997) Dengue virus infection: epidemiology, pathogenesis, clinical presentation, diagnosis and prevention. J Pediatr 131: 516–524PubMedCrossRefGoogle Scholar
  204. Robertson SE, Hull BP, Tomori O, Bele O, LeDuc JW, Esteves K (1996) Yellow fever. A decade of reemergence. JAMA 276: 1157–1162Google Scholar
  205. Tsai TF (1997) Ebola and Marburg viruses. In: Long SS, Pickering LK, Prober CG (eds) Pediatric infectious diseases. Churchill Livingstone, New York, 1274–1275Google Scholar
  206. Tsai TF (1997) Lymphocytic choriomeningitis virus, Lassa fever virus, and other arenaviruses. In: Long SS, Pickering LK, Prober CG (eds) Pediatric infectious diseases. Churchill Livingstone, New York, 1275–1278Google Scholar
  207. Bear GM (ed) (1991) The natural history of rabies, 2nd edn. CRC, Boca Raton/FLGoogle Scholar
  208. Roß RS, Kruppenbacher JP, Schiller WG et al. (1997) Menschliche Tollwuterkrankung in Deutschland. Dtsch Ärzteblatt 94: 29–32Google Scholar
  209. Armstrong D, Schmitt HJ (1990) Older drugs.Amphotericin B and 5-fluorocytosine. In: Ryley JF (ed) Chemotherapy of fungal diseases. Springer, Berlin Heidelberg New York Tokyo (Handbook of experimental pharmacology, vol 96, pp 439–454Google Scholar
  210. Groll AH, Piscitelli SC, Walsh TJ (1998) Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development. Adv Pharmacol 44: 343–500PubMedCrossRefGoogle Scholar
  211. Larone DH (1987) Medically important fungi. A guide to identification. Elsevier, New YorkGoogle Scholar
  212. Schmitt HJ, Armstrong D (1996) Antifungal chemotherapy. In: Kass EH, Platt R (eds) Current therapy in infectious diseases-3. BC Decker, Toronto, pp 12–17Google Scholar
  213. Seeliger HPR, Heymer T (1981) Diagnostik pathogener Pilze des Menschen und seiner Umwelt. Thieme, StuttgartGoogle Scholar
  214. Ballou WP (1994) Clinical trials of Plasmodium falciparum erythrocytic stage vaccines. Am J Trop Med Hyg 50: 59–65PubMedGoogle Scholar
  215. Baum J (1995) Infections of the eye. Clin Inf Dis 21: 479–488CrossRefGoogle Scholar
  216. Burchard GD (1998) Erkrankungen bei Immigranten. Diagnostik, Therapie, Begutachtung. G. Fischer, StuttgartGoogle Scholar
  217. Feigin RD, Cherry JD (eds) (1998) Textbook of pediatric infectious diseases, 4th edn. Saunders, PhiladelphiaGoogle Scholar
  218. Glickman LT, Magnaval JF (1993) Zoonotic roundworm infections. Brit J Hosp Med 51: 402–408Google Scholar
  219. Gönnert R, König K (1968) The microscopic diagnosis of tropical diseases. Bayer, LeverkusenGoogle Scholar
  220. Harinasuta T, Pungpak S, Keystone JS (1993) Trematode infections: opisthorchiasis, clonorchiasis, fascioliasis, and paragonimiasis. Inf Dis Clin North Am 7: 699–716Google Scholar
  221. Jong EC, McMullen R (eds) (1995) The travel and tropical medicine manual. Saunders, PhiladelphiaGoogle Scholar
  222. Kammerer WS, Schantz PM (1993) Echinococcal disease. Inf Dis Clin North Am 7: 605–618Google Scholar
  223. Kenney RT (1994) Parasitic causes of diarrhea. Pediatr Ann 23: 414–422PubMedGoogle Scholar
  224. Knobloch J (Hrsg) (1996) Tropen- und Reisemedizin. G. Fischer, Jena StuttgartGoogle Scholar
  225. Lang W (Hrsg) (1999) Tropenmedizin in Klinik und Praxis, 3. Auf. Thieme, Stuttgart New YorkGoogle Scholar
  226. Liu LX, Weller PF (1993) Strongyloidiasis and other intestinal nematode infections. Inf Dis Clin North Am 7: 655–682Google Scholar
  227. Lowichik A, Ruff AJ (1995) Parasitic infections of the central nervous system in children. Part II: disseminated infections. J Child Neurol 10: 77–87PubMedCrossRefGoogle Scholar
  228. Lowichik A, Ruff AJ (1995) Parasitic infections of the central nervous system in children. Part III: space occupying lesions. J Child Neurol 10: 177–190PubMedCrossRefGoogle Scholar
  229. Lowichik A, Siegel JD (1995) Parasitic infections of the central nervous system in children. Part I: Congential infections and meningoencephalitis. J Child Neurol 10: 4–17Google Scholar
  230. Ravdin JI (1995) Amebiasis. Clin Infect Dis 20: 1453–1466CrossRefGoogle Scholar
  231. Steele RW, Baffoe-Bonnie B (1995) Cerebral malaria in children. Pediatr Infect Dis J 14: 281–285PubMedCrossRefGoogle Scholar
  232. Weiss JB (1995) DNA-probes and PCR for diagnosis of parasitic infections. Clin Microbiol Rev 8: 113–130PubMedGoogle Scholar
  233. WHO (1999) Aktuelle Daten zur Prävalenz und Inzidenz von Tropenkrankheiten. http://www.who.int/ctd/

Copyright information

© Springer-Verlag Berlin Heidelberg 2001

Authors and Affiliations

  • H.-J. Schmitt
  • Th. Hauer
  • F. Daschner
  • M. Hufnagel
  • H. Scholz
  • B. Jüngst
  • H.-I. Huppertz
  • K.-M. Keller
  • H.-J. Christen
  • H. Eiffert
  • U. Heininger
  • D. Nadal
  • J. Forster
  • H. W. Kreth
  • V. Schuster
  • M. B. Krawinkel

There are no affiliations available

Personalised recommendations